Literature DB >> 27794633

Molecular dynamics simulations of aptamer-binding reveal generalized allostery in thrombin.

Jiajie Xiao1, Freddie R Salsbury1.   

Abstract

Thrombin is an attractive target for antithrombotic therapy due to its central role in thrombosis and hemostasis as well as its role in inducing tumor growth, metastasis, and tumor invasion. The thrombin-binding DNA aptamer (TBA), is under investigation for anticoagulant drugs. Although aptamer binding experiments have been revealed various effects on thrombin's enzymatic activities, the detailed picture of the thrombin's allostery from TBA binding is still unclear. To investigate thrombin's response to the aptamer-binding at the molecular level, we compare the mechanical properties and free energy landscapes of the free and aptamer-bound thrombin using microsecond-scale all-atom GPU-based molecular dynamics simulations. Our calculations on residue fluctuations and coupling illustrate the allosteric effects of aptamer-binding at the atomic level, highlighting the exosite II, 60s, γ and the sodium loops, and the alpha helix region in the light chains involved in the allosteric changes. This level of details clarifies the mechanisms of previous experimentally demonstrated phenomena, and provides a prediction of the reduced autolysis rate after aptamer-binding. The shifts in thrombin's ensemble of conformations and free energy surfaces after aptamer-binding demonstrate that the presence of bound-aptamer restricts the conformational freedom of thrombin suggesting that conformational selection, i.e. generalized allostery, is the dominant mechanism of thrombin-aptamer binding. The profound perturbation on thrombin's mechanical and thermodynamic properties due to the aptamer-binding, which was revealed comprehensively as a generalized allostery in this work, may be exploited in further drug discovery and development.

Entities:  

Keywords:  aptamer; generalized allostery; molecular dynamics; molecular recognition; thrombin

Mesh:

Substances:

Year:  2016        PMID: 27794633      PMCID: PMC6876308          DOI: 10.1080/07391102.2016.1254682

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  66 in total

1.  Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.

Authors:  Ingrid M Verhamme; Steven T Olson; Douglas M Tollefsen; Paul E Bock
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

2.  Engineered thrombin aims to take on heparin.

Authors:  Jeanne Erdmann
Journal:  Chem Biol       Date:  2010-12-22

3.  Insights into correlated motions and long-range interactions in CheY derived from molecular dynamics simulations.

Authors:  Michael H Knaggs; Freddie R Salsbury; Marshall Hall Edgell; Jacquelyn S Fetrow
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

4.  Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor.

Authors:  Freddie R Salsbury; Michael W Crowder; Stephen F Kingsmore; James J A Huntley
Journal:  J Mol Model       Date:  2008-11-28       Impact factor: 1.810

5.  The anticoagulants market.

Authors:  Irena Melnikova
Journal:  Nat Rev Drug Discov       Date:  2009-04-24       Impact factor: 84.694

6.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

Review 7.  Development of aptamer oligonucleotides as anticoagulants and antithrombotics for cardiovascular diseases: current status.

Authors:  Weibin Li; Kaiyu Wang; Meng Zhao; Xiangyue Yang; Min Chen; Xiaopeng Lan
Journal:  Thromb Res       Date:  2014-05-22       Impact factor: 3.944

8.  Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin.

Authors:  T Takagi; R F Doolittle
Journal:  Biochemistry       Date:  1974-02-12       Impact factor: 3.162

Review 9.  Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype.

Authors:  Mary Lynn Nierodzik; Simon Karpatkin
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

10.  Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface.

Authors:  A Reza Radjabi; Kenjiro Sawada; Sujatha Jagadeeswaran; Alfred Eichbichler; Hilary A Kenny; Anthony Montag; Katharina Bruno; Ernst Lengyel
Journal:  J Biol Chem       Date:  2007-11-29       Impact factor: 5.157

View more
  7 in total

1.  Visualizing correlated motion with HDBSCAN clustering.

Authors:  Ryan L Melvin; Jiajie Xiao; Ryan C Godwin; Kenneth S Berenhaut; Freddie R Salsbury
Journal:  Protein Sci       Date:  2017-09-06       Impact factor: 6.725

2.  Binding Site Configurations Probe the Structure and Dynamics of the Zinc Finger of NEMO (NF-κB Essential Modulator).

Authors:  Ryan C Godwin; Ryan L Melvin; William H Gmeiner; Freddie R Salsbury
Journal:  Biochemistry       Date:  2017-01-13       Impact factor: 3.162

3.  Simulations suggest double sodium binding induces unexpected conformational changes in thrombin.

Authors:  Dizhou Wu; Freddie R Salsbury
Journal:  J Mol Model       Date:  2022-04-13       Impact factor: 2.172

4.  Light Chain Mutation Effects on the Dynamics of Thrombin.

Authors:  Dizhou Wu; Jiajie Xiao; Freddie R Salsbury
Journal:  J Chem Inf Model       Date:  2021-01-15       Impact factor: 4.956

Review 5.  Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System.

Authors:  Ildiko M Kovach
Journal:  Life (Basel)       Date:  2021-04-27

Review 6.  Molecular Modeling Applied to Nucleic Acid-Based Molecule Development.

Authors:  Arne Krüger; Flávia M Zimbres; Thales Kronenberger; Carsten Wrenger
Journal:  Biomolecules       Date:  2018-08-27

7.  Impact of the Position of the Chemically Modified 5-Furyl-2'-Deoxyuridine Nucleoside on the Thrombin DNA Aptamer-Protein Complex: Structural Insights into Aptamer Response from MD Simulations.

Authors:  Preethi Seelam Prabhakar; Richard A Manderville; Stacey D Wetmore
Journal:  Molecules       Date:  2019-08-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.